Novo dips 6% on Wegovy pill stumble despite Q2 earnings beat
Novo Nordisk’s shares fell 6% on Tuesday afternoon after its second quarter earnings report showed a slight miss for the Wegovy pill vs. consensus.
Read the full article on the original site.
Read Full Article